Re:Cognition Health, a leading provider of final phase, international, clinical trials for Alzheimer’s disease and other neurological conditions, has launched a new centre in Birmingham.
Located in the Calthorpe Medical Estate, at 100 Hagley Road Road, B16 8LT, the new site will provide access to the very best healthcare and treatment options for Alzheimer’s disease and related conditions, whilst pioneering research to ultimately help pave the way to finding a cure for the disease.
With over 130,000 people living with a diagnosis of dementia in the Midlands, Re:Cognition Health aims to support individuals with memory loss and other symptoms of cognitive impairment through providing education, clinical excellence and access to the most advanced treatments available worldwide.
Dr Emer MacSweeney, chief executive and medical director of Re:Cognition Health, said: “We are delighted to be launching this major clinical studies centre in Birmingham, offering individuals the opportunity to have access to life changing treatment and medication.”
Dr Jo Rodda, consultant cognitive expert at Re:Cognition Health and Clinical Lead at the new Birmingham centre added: “We are able to offer the opportunity to be involved in clinical trials of the next generation of emerging medications. Participants receive outstanding medical care and are monitored regularly throughout the study by a team of cognitive experts; we are looking forward to making a difference to the lives of people in the Midlands.”
All medical costs are covered by the pharmaceutical company, so the very best care and medical facilities are provided at no cost to the individual.
It is an exciting time for research into Alzheimer’s disease and other causes of mild cognitive impairment (MCI) and dementia. Results from clinical trials are always encouraging, bringing us ever closer to treatments to slow down or, ideally, halt the progression of the disease and to improve its symptoms.
Why clinical trials?
Clinical trials are essential for advancing our understanding of medicine and improving the healthcare and quality of life for everyone affected by dementia and cognitive impairment. By participating in an international clinical study, individuals can gain the potential personal benefit of early access to a new treatment, whilst also having an important global impact on our ability to treat a given condition.
Dr MacSweeney said: “With the introduction of new biomarkers to detect evidence of Alzheimer’s disease at its earliest stage, there is reason for cautious optimism that new generation medications will delay progression of disease and also boost cognition. Just as research through clinical studies has improved our outlook for numerous diseases including previously fatal infections and certain forms of cancer; the same action is being taken today for Alzheimer’s disease.”
Re:Cognition Health is proud of the pioneering work being undertaken by the consultants and cognitive experts at the clinic and continues to work hard to become one of the most successful clinics in the world for enrolling individuals onto final phase international clinical trials for Alzheimer’s Disease.
An early diagnosis is essential to have a change to change your future.
10 early symptoms of cognitive impairment which may lead to dementia include:
- Short term memory loss such as forgetting names and important dates and repeatedly asking the same questions
- Changes in behaviour – unexpected & uncharacteristic anger and changes in mood, perhaps becoming passive and disinterested
- Confusion which could include losing track of time or problems with processing information
- Forgetting words and experiencing problems with speech and language
- Loss of sense of direction, getting lost in a familiar environment and disorientated
- Difficulty in performing everyday (seemingly normal)tasks such as making a cup of tea or unpacking the grocery shopping
- Problems with calculation – managing money or completing simple sums and puzzles may become an issue
- Misplacing items such as putting keys in freezer or milk in the dishwasher and not being able to retrace steps to find them
- Difficulty making decisions which may also include making the wrong decision such as personal grooming
- Issues with visual images and spacial awareness which may include difficulty reading words, judging distances or recognising colour contrast
